A variety of drugs have been developed in the last fifty years and are currently used to control the disability related to Parkinson's disease (PD): levodopa, dopamine-agonists, monoaminoxidase B inhibitors, catechol-O-methyltransferase inhibitors. The gene discussed is MAOB; the disease is Parkinson disease.